FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting FDA Peptide Reclassification 2026: What It Means for Providers Big news for mens health. The FDA is officially advancing 12 high demand peptides including BPC 157, GHK Cu, and TB500 toward the next phase this July clearing the path for broader access and renewed The Blacklisting of Peptides New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, FDA Announces Removal of 12 Peptides from Category 2 and Schedules PCAC Meetings to Consider Adding Peptides to 503A Bulk Drug Substances List